Suppr超能文献

光变构调节剂 Photo-BQCA:实现 M 受体光学控制的正变构调节剂

Photo-BQCA: Positive Allosteric Modulators Enabling Optical Control of the M Receptor.

机构信息

Pharmaceutical and Medicinal Chemistry Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg (JMU), Am Hubland, 97074, Würzburg, Germany.

Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Carrer de Baldiri Reixac, 10-12, 08028, Barcelona, Spain.

出版信息

Angew Chem Int Ed Engl. 2024 Nov 18;63(47):e202411438. doi: 10.1002/anie.202411438. Epub 2024 Oct 8.

Abstract

The field of G protein-coupled receptor (GPCR) research has greatly benefited from the spatiotemporal resolution provided by light controllable, i.e., photoswitchable ligands. Most of the developed tools have targeted the Rhodopsin-like family (Class A), the largest family of GPCRs. However, to date, all such Class A photoswitchable ligands were designed to act at the orthosteric binding site of these receptors. Herein, we report the development of the first photoswitchable allosteric modulators of Class A GPCRs, designed to target the M muscarinic acetylcholine receptor. The presented benzyl quinolone carboxylic acid (BQCA) derivatives, Photo-BQCisA and Photo-BQCtrAns, exhibit complementary photopharmacological behavior and allow reversible control of the receptor using light as an external stimulus. This makes them valuable tools to further investigate M receptor signaling and a proof of concept for photoswitchable allosteric modulators at Class A receptors.

摘要

G 蛋白偶联受体(GPCR)研究领域极大地受益于光可控,即光致变色配体提供的时空分辨率。大多数开发的工具都针对视紫红质样家族(A 类),这是 GPCR 最大的家族。然而,迄今为止,所有此类 A 类光致变色配体都是为作用于这些受体的正位结合位点而设计的。在此,我们报告了第一种针对 A 类 GPCR 的光致变构调节剂的开发,旨在针对 M 毒蕈碱乙酰胆碱受体。所呈现的苄基喹啉羧酸(BQCA)衍生物,Photo-BQCisA 和 Photo-BQCtrAns,表现出互补的光药理行为,并允许使用光作为外部刺激来可逆地控制受体。这使它们成为进一步研究 M 受体信号的有价值的工具,并且是 A 类受体的光致变构调节剂的概念验证。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验